Marketwatch Tata Capital to invest ₹225 cr. in Biocon Biologics for 0.85% stake Admin July 31, 2020 Deal values Biocon Biologics an equity valuation of $3.5 billion. – The Hindu – Industry Share on Facebook Tweet it Pin it Share it Email